Event Type:
Webinar
Category:
Priority Topic
Date:
April 29, 2020
Time:
2:00 - 3:00 PM ET
The lack of economic and cost-effectiveness analyses within the implementation science portfolio, highlights a need to focus on methodological and measurement issues, as well as field capacity, to better understand what the implementation costs are and who bears them, and to distinguish between the intervention versus implementation costs. This webinar discusses how these questions were addressed at the first Implementation Science Consortium in Cancer (ISCC) in 2019 and next steps for the field.
Speakers
Dr. Heather Taffet Gold
NYU Langone Health
Dr. Gila Neta
National Cancer Institute
Dr. Todd Wagner
Stanford University
Last Updated
July 13, 2023